Nektar Therapeutics
(NASDAQ:NKTR)
$2.88
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$2.88
PreMarket: 4:02PM EDT
Day Range- - -52 Wk Range2.73 - 15.95Open / Close- / -Float / Outstanding122.7M / 188M
Vol / Avg.- / 1.8MMkt Cap541.3MP/E-50d Avg. Price3.47
Div / Yield-Payout Ratio-Total Float122.7MEPS-0.31

Nektar Therapeutics Stock (NASDAQ:NKTR), Quotes and News Summary

Nektar Therapeutics Stock (NASDAQ: NKTR) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range2.73 - 15.95Open / Close- / -Float / Outstanding122.7M / 188M
Vol / Avg.- / 1.8MMkt Cap541.3MP/E-50d Avg. Price3.47
Div / Yield-Payout Ratio-Total Float122.7MEPS-0.31
Seeking Alpha - Nov 18, 2022, 5:50PM
Seeking Alpha - Nov 2, 2022, 5:35PM
TipRanks - Oct 7, 2022, 6:33AM
Seeking Alpha - Aug 3, 2022, 5:35PM
Seeking Alpha - Jul 17, 2022, 12:51PM
Sector: Health Care.Industry: Pharmaceuticals
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, the company is focused on activating the immune system's natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.450-0.310 0.1400
REV22.610M23.625M1.015M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Nektar Therapeutics (NKTR) stock?

A

You can purchase shares of Nektar Therapeutics (NASDAQ: NKTR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Nektar Therapeutics's (NKTR) competitors?

Q

What is the target price for Nektar Therapeutics (NKTR) stock?

A

The latest price target for Nektar Therapeutics (NASDAQ: NKTR) was reported by JP Morgan on Monday, August 8, 2022. The analyst firm set a price target for 0.00 expecting NKTR to fall to within 12 months (a possible -100.00% downside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Nektar Therapeutics (NKTR)?

A

The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $2.88 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Nektar Therapeutics (NKTR) pay a dividend?

A

There are no upcoming dividends for Nektar Therapeutics.

Q

When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?

A

Nektar Therapeutics’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Nektar Therapeutics (NKTR) going to split?

A

There is no upcoming split for Nektar Therapeutics.

Q

What sector and industry does Nektar Therapeutics (NKTR) operate in?

A

Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.